Breaking News Bar

Business News and Information

Pfizer says could apply for U.S. emergency use approval for vaccine in late November

Pfizer said on Friday it would apply for emergency use in the U.S. of its Covid-19 vaccine candidate as soon as a safety milestone is achieved in the third week of November.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear